SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/CF9335F2161EFDEBD9547908506AADF6A99B24269991A2D7F63EDC36F2013B04C2154776EAB538FD1D14232CED4CFA50>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/CF9335F2161EFDEBD9547908506AADF6A99B24269991A2D7F63EDC36F2013B04C2154776EAB538FD1D14232CED4CFA50
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/CF9335F2161EFDEBD9547908506AADF6A99B24269991A2D7F63EDC36F2013B04C2154776EAB538FD1D14232CED4CFA50
http://www.w3.org/2000/01/rdf-schema#comment
"Circulatory EPO may be a useful biomarker for coronary collateral development and potential target for therapeutic angiogenesis in patients with chronic total occlusion"
xsd:string
http://purl.uniprot.org/uniprot/#_3B9B5211E484F8940C85C38980D1BAB4B1462DAD4CA37AFD37475975C0E76259153C7825B698759AE1309D270DD3091D
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/CF9335F2161EFDEBD9547908506AADF6A99B24269991A2D7F63EDC36F2013B04C2154776EAB538FD1D14232CED4CFA50
http://purl.uniprot.org/uniprot/U3MHQ9
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/CF9335F2161EFDEBD9547908506AADF6A99B24269991A2D7F63EDC36F2013B04C2154776EAB538FD1D14232CED4CFA50
http://purl.uniprot.org/uniprot/#_U3MHQ9-mappedCitation-23672497
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/CF9335F2161EFDEBD9547908506AADF6A99B24269991A2D7F63EDC36F2013B04C2154776EAB538FD1D14232CED4CFA50